Hostname: page-component-669899f699-2mbcq Total loading time: 0 Render date: 2025-04-27T04:38:19.509Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France

Published online by Cambridge University Press:  21 September 2023

Tess Martin Open the ORCID record for Tess Martin [Opens in a new window] ,
Alessandra Guercio ,
Hélène Besseau ,
Laure Huot Open the ORCID record for Laure Huot [Opens in a new window] ,
Pascale Guerre Open the ORCID record for Pascale Guerre [Opens in a new window] ,
Jamal Atfeh ,
Laurent Piazza ,
Judith Pineau ,
Brigitte Sabatier  and
Isabelle Borget Open the ORCID record for Isabelle Borget [Opens in a new window]
...Show all authors
Tess Martin
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
Alessandra Guercio
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
Hélène Besseau
Affiliation:
Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
Laure Huot
Affiliation:
Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France Université Lyon 1, INSERM U1290 Research on Healthcare Performance RESHAPE, Lyon, France
Pascale Guerre
Affiliation:
Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France Lyon University, Univ. Claude Bernard Lyon 1, P2S UR4129, Lyon, France
Jamal Atfeh
Affiliation:
Hospices Civils de Lyon, Pôle de Santé Publique, Service Evaluation Economique en santé, Lyon, France
Laurent Piazza
Affiliation:
Health Economics Unit, Clinical Research Department, Bordeaux University Hospital, Talence, France
Judith Pineau
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
Brigitte Sabatier
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France
Isabelle Borget
Affiliation:
Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France Inserm, Université Paris-Saclay, CESP U1018, Oncostat, Certified Ligue Contre le Cancer, Villejuif, France
Nicolas Martelli*
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, Paris, France Faculty of Pharmacy, Paris-Saclay University, GRADES, Orsay, France
*
Corresponding author: Nicolas Martelli; Email: nicolas.martelli@aphp.fr
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

To better understand the process of hospital acquisition of innovative medical devices (MDs) and the hospital-based health technology assessment (HB-HTA) pathways in France, an in-depth study based on a quantitative approach is needed. The aim of the present study was to assess through a national survey how HB-HTA is currently implemented in French hospitals and to identify its level of formalization.

Methods

A quantitative online survey was conducted among hospitals performing HB-HTA in France, with a focus on the acquisition of innovative MDs for individual use. The survey, conducted between March and June 2022, was developed by a scientific board composed of members of the French-speaking Society for HB-HTA.

Results

Sixty-seven out of 131 surveyed hospitals with HB-HTA activities responded, including 29 university hospitals, 24 nonprofit private hospitals, and 14 local hospitals. Sixty-one respondents (91 percent) reported the existence of a process dedicated to evaluating innovative MDs; of these, 16 declared that their hospitals had a formalized unit with HB-HTA activity. These units were more frequently found in larger hospitals with more than 500 inpatient beds (n = 16, p = 0.0160) and in university hospitals (n = 12, p = 0.0158). No hospital reported any collaboration with HAS, the French national HTA agency.

Conclusion

A diverse range of HB-HTA organizations with different structural levels exist in France for MD procurement linked to the category of hospitals. The study highlights the need for recognition of HB-HTA activity at the regulatory level in France and for direct collaboration between HTA activities performed at local and national levels.

Keywords

medical deviceshospital-based HTAprocurementtherapeutic innovations
Type
Policy
Information
International Journal of Technology Assessment in Health Care , Volume 39 , Issue 1 , 2023 , e58
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Hinrichs-Krapels, S, Ditewig, B, Boulding, H, et al. Purchasing high-cost medical devices and equipment in hospitals: A systematic review. BMJ Open. 2022;12(9):e057516.CrossRefGoogle ScholarPubMed
Sorenson, C, Kanavos, P. Medical technology procurement in Europe: A cross-country comparison of current practice and policy. Health Policy Amst Neth. 2011;100(1):43–50.CrossRefGoogle ScholarPubMed
Sorenson, C, Chalkidou, K. Reflections on the evolution of health technology assessment in Europe. Health Econ Policy Law. 2012;7(1):25–45.CrossRefGoogle ScholarPubMed
Sampietro-Colom, L, Martin, J, editors. Hospital-based health technology assessment: The next Frontier for health technology assessment [Internet]. Cham: Springer International Publishing; 2016 [cited 2023 July 6]. Available from: https://doi.org/10.1007/978-3-319-39205-9.CrossRefGoogle Scholar
Gagnon, MP. Hospital-based health technology assessment: Developments to date. PharmacoEconomics. 2014;32(9):819–824.CrossRefGoogle ScholarPubMed
Martelli, N, Puc, C, Szwarcensztein, K, et al. Hospital-based health technology assessment in France: A focus on medical devices. Therapies. 2017;72(1):115–123.CrossRefGoogle Scholar
Robinson, JC, Jarrion, Q. Competition from biosimilars drives price reductions for biologics in the French single-payer health system. Health Aff. 2021;40(8):1190–1197.CrossRefGoogle ScholarPubMed
Martelli, N, Devaux, C, van den Brink, H, et al. Harmonizing health technology assessment practices in university hospitals: To what extent is the mini-HTA model suitable in the French context? Int J Technol Assess Health Care. 2017;33(2):307–314.CrossRefGoogle ScholarPubMed
Martelli, N, Billaux, M, Borget, I, et al. Introduction of innovative medical devices at French university hospitals: An overview of hospital-based health technology assessment initiatives. Int J Technol Assess Health Care. 2015;31(1–2):12–18.CrossRefGoogle ScholarPubMed
Cicchetti, A, Marchetti, M, Dibidino, R. Hospital based health technology assessment world-wide survey. Health Technology Assessment International, Hospital Based Health Technology Assessment Sub-Interest Group. [Internet]. [cited 2022 Nov 20]. Available from: http://www.htai.org/fileadmin/HTAi_Files/ISG/HospitalBasedHTA/2008Files/HospitalBasedHTAISGSurveyReport.pdf.Google Scholar
Sampietro-Colom, L, Lach, K, Pasternack, I, et al. Guiding principles for good practices in hospital-based health technology assessment units. Int J Technol Assess Health Care. 2015;31(6):457–465.CrossRefGoogle ScholarPubMed
Samprietro-Colom, L, Lach, K, Escolar, I, et al. A handbook and a toolkit for hospital-based health technology assessment. Value Health. 2015;18:A556.CrossRefGoogle Scholar
Cicchetti, A, Iacopino, V, Coretti, S, et al. Toward a contingency model for hospital-based health technology assessment: evidence from adhophta project. Int J Technol Assess Health Care. 2018;34(2):205–211.CrossRefGoogle Scholar
Gałązka-Sobotka, M, Kowalska-Bobko, I, Lach, K, et al. Recommendations for the implementation of hospital based HTA in Poland: Lessons learned from international experience. Front Pharmacol. 2020;11:594644.CrossRefGoogle ScholarPubMed
Cangelosi, M, Chahar, A, Eggington, S. Evolving use of Health Technology Assessment in Medical Device Procurement – A Global Systematic Review: An ISPOR Special Interest Group Report. Value Health [Internet]. 2023 June 21 [cited 2023 July 10]; Available from: https://www.sciencedirect.com/science/article/pii/S1098301523030206.CrossRefGoogle Scholar
Nardi, PM. Doing survey research: A guide to quantitative methods. 4th ed. New York: Routledge; 2018. 272 p.CrossRefGoogle Scholar
Callea, G, Armeni, P, Marsilio, M, Jommi, C, Tarricone, R. The impact of HTA and procurement practices on the selection and prices of medical devices. Soc Sci Med. 2017;174:89–95.CrossRefGoogle ScholarPubMed
Mitchell, MD, Williams, K, Brennan, PJ, Umscheid, CA. Integrating local data into hospital-based healthcare technology assessment: Two case studies. Int J Technol Assess Health Care. 2010;26(3):294–300.CrossRefGoogle ScholarPubMed
Kidholm, K, Ehlers, L, Korsbek, L, Kjaerby, R, Beck, M. Assessment of the quality of mini-HTA. Int J Technol Assess Health Care. 2009;25(1):42–48.CrossRefGoogle ScholarPubMed
Martin, J, Polisena, J, Dendukuri, N, Rhainds, M, Sampietro-Colom, L. Local health technology assessment in canada: Current state and next steps. Int J Technol Assess Health Care. 2016;32(3):175–180.CrossRefGoogle ScholarPubMed
Gagnon, M-P. Opportunities to promote efficiency in hospital decision-making through the use of health technology assessment | Read Portal [Internet]. [cited 2023 Jan 11]. Available from: https://read.chcm.ubc.ca/2012/02/24/opportunities-to-promote-efficiency-in-hospital-decision-making-through-the-use-of-health-technology-assessment/.Google Scholar
Dimitrova, M, Jakab, I, Mitkova, Z, et al. Potential barriers of patient involvement in health technology assessment in central and Eastern European countries. Front Public Health. 2022;10:922708.CrossRefGoogle ScholarPubMed
Roussel, C, Chassany, O, Durand-Zaleski, I, et al. Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France. Therapie. 2022;77(1):103–115.CrossRefGoogle ScholarPubMed
Supplementary material: File

Martin et al. supplementary material
Download undefined(File)
File 24.8 KB